Quick Answer
AdaptHealth Corp. reported Diluted EPS of $0.52 per share (loss) for fiscal year 2025.
AdaptHealth Corp. Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2025 | -$0.52 | -185.2% |
| 2024 | $0.61 | +111.5% |
| 2023 | -$5.31 | -1709.1% |
| 2022 | $0.33 | -50.7% |
| 2021 | $0.67 | +121.8% |
| 2020 | -$3.08 | -224.2% |
| 2019 | -$0.95 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $0.16 | +6.7% | +60.0% |
| June 30, 2025 | $0.10 | -23.1% | +300.0% |
| March 31, 2025 | -$0.05 | -150.0% | -133.3% |
| September 30, 2024 | $0.15 | +104.4% | +15.4% |
| June 30, 2024 | $0.13 | +44.4% | +750.0% |
| March 31, 2024 | -$0.02 | +66.7% | +99.4% |
| September 30, 2023 | -$3.43 | -3218.2% | -3911.1% |
| June 30, 2023 | $0.09 | +0.0% | +250.0% |
- AdaptHealth Corp. showed a decrease of -185.2% in Diluted EPS compared to the prior fiscal year.
- Over the 2019–2025 period, AdaptHealth Corp.’s diluted eps has grown by 45.3% (from $0.95 per share (loss) to $0.52 per share (loss)).
- The most recent figure is from AdaptHealth Corp.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 24, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: